Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
| Product: | Hizentra NZ (1g/5ml) |
| Active Ingredient: | Immunoglobulin G 200mg/mL |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | CSL Behring (NZ) Limited |
| Manufacturer: | CSL Behring (Australia) Pty Limited, Melbourne, Australia |
| Product: | Hizentra NZ (2g/10ml) |
| Active Ingredient: | Immunoglobulin G 200mg/mL |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | CSL Behring (NZ) Limited |
| Manufacturer: | CSL Behring (Australia) Pty Limited, Melbourne, Australia |
| Product: | Hizentra NZ (4g/20ml) |
| Active Ingredient: | Immunoglobulin G 200mg/mL |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | CSL Behring (NZ) Limited |
| Manufacturer: | CSL Behring (Australia) Pty Limited, Melbourne, Australia |
Dated this 5th day of May 2023.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).